Best Supplements for Reduced Oral Mucositis Severity
Ranked by research evidence. Compare 22 supplements across 32 papers from the biomedical literature, with effect direction, evidence strength, and dose range for each.
Top picks by evidence
- Moderate evidence5 studies
Across 5 studies, 3 reported beneficial effects (one moderate, two small) and 2 found neutral effects on reducing oral mucositis severity. Most evidence comes from clinical populations with cancer, particularly head and neck cancer patients undergoing radiotherapy or chemoradiotherapy. The median study duration was 49 days, and the most-studied dose was 5 g of L-glutamine (in one RCT), though dose information was limited across the included papers.
Dose: 5 g daily (single trial) - Low evidence3 studies
Across 3 studies, 2 reported beneficial effects of aloe vera on reducing oral mucositis severity, with effect sizes ranging from small to moderate. One systematic review found neutral effects in pediatric cancer patients, while a meta-analysis and a systematic review in broader cancer populations showed statistically significant benefits. The evidence is limited to clinical populations, primarily adults with cancer, but study durations and doses were not consistently reported.
- ModerateL-GlutamineAcross 5 studies, 3 reported beneficial effects (one moderate, two small) and 2 found neutral effects on reducing oral mucositis severity. Most evidence comes from clinical populations with cancer, particularly head and neck cancer patients undergoing radiotherapy or chemoradiotherapy. The median study duration was 49 days, and the most-studied dose was 5 g of L-glutamine (in one RCT), though dose information was limited across the included papers. · Dose: 5 g daily (single trial)3 beneficial2 neutral5 studies
- LowAloe VeraAcross 3 studies, 2 reported beneficial effects of aloe vera on reducing oral mucositis severity, with effect sizes ranging from small to moderate. One systematic review found neutral effects in pediatric cancer patients, while a meta-analysis and a systematic review in broader cancer populations showed statistically significant benefits. The evidence is limited to clinical populations, primarily adults with cancer, but study durations and doses were not consistently reported.2 beneficial1 neutral3 studies